• Home
  • Columbus State University
  • American Government POLS 1101
  • Healthcare Regulations and Policies

Healthcare Regulations and Policies

POLS 1101 Nathan Combes March 27,2018 Possible Laws Regarding the Financial Costs in Healthcare Almost everybody knows that America's drug prices are increasing at a steady rate and they are furious about it, but it seems there is nothing to stop it. Recently there have been stories about insurance companies putting obstacles between consumers and less risky medications with lower prices. Between 2006 and 2015, pharmaceutical and biotechnology sales revenue increased from $534 billion to $775 billion. "Drug companies raise prices far exceeding inflation because they can," said Scott Knoer, chief pharmacy officer at the Cleveland Clinic. "In the absence of regulation and without consumer awareness--since consumers don't generally see the price due to insurance--the sky is the limit." So what laws can be put in place to stop all of this? In order to start lowering these drug prices, we must start regulating the corporations behind the brand-name drugs. Approximately 48 percent of prescription products are available only in a brand-name product. According to the National Conference of State Legislatures, the FDA has an upcoming strategy that involves the states controlling the costs of prescription drugs through preferred drug lists, extra manufacturer price rebates, multistate purchasing and negotiations, and scientific studies on comparative effectiveness. State Medicaid programs will save between 8 percent and 12 percent on all Medicaid drug purchases. This will lead to savings to states nationwide an average $1.8 billion annually. The FDA claims they are trying to fix the problem of brand-name drug manufacturers blocking generic drug companies. This leads to another one of the FDA's effective strategies. This strategy will lead to the use of generic prescription drugs and the use of discounts on brand- name drugs. This will be done through state government-funded pharmaceutical purchasing state-only programs and some private-market pharmaceutical purchasing. They believe this will lead to consumers saving 30 to 80 percent on certain widely used medications.